Tivicay® (dolutegravir) 50-mg tablets for HIV-1
FDA has approved Viiv Healthcare’s integrase inhibitor Tivicay® (dolutegravir) 50-mg tablets, for use with other antiretroviral agents in treating HIV-1 infection. ViiV Healthcare is an HIV therapeutics company established in 2009 by GlaxoSmithKline and Pfizer. Tivicay is indicated for...Tags: HIV-1, HIV, Drug, Computational Chemistry
3877 days ago
Tags: Programming, Research in life science, Computational Chemistry, Genomics, System biology, Innovating new ideas.
2779 days ago
Tags: DST-SERB, Winter School, Computational Chemistry, WSCC – 2013
3792 days ago
Skills: Genomics, Proteomics, computational chemistry, bioinformatics
3457 days ago